Literature DB >> 33517344

Novel exon-skipping variant disrupting the basic domain of HCFC1 causes intellectual disability without metabolic abnormalities in both male and female patients.

Parith Wongkittichote1, Daniel J Wegner2, Marwan S Shinawi3.   

Abstract

HCFC1, a global transcriptional regulator, has been shown to associate with MMACHC expression. Pathogenic variants in HCFC1 cause X-linked combined methylmalonic acidemia and hyperhomocysteinemia, CblX type (MIM# 309541). Recent studies showed that certain variants in HCFC1 are associated with X-linked intellectual disability with mild or absent metabolic abnormalities. Here, we report five subjects (three males, two females) from the same family with a novel predicted loss of function HCFC1 variant. All five patients exhibit developmental delay or intellectual disability/learning difficulty and some dysmorphic features; findings were milder in the female as compared to male subjects. Biochemical studies in all patients did not show methylmalonic acidemia or hyperhomocysteinemia but revealed elevated vitamin B12 levels. Trio exome sequencing of the proband and his parents revealed a maternally inherited novel variant in HCFC1 designated as c.1781_1803 + 3del26insCA (NM_005334). Targeted testing confirmed the presence of the same variant in two half-siblings and maternal great uncle. In silico analysis showed that the variant is expected to reduce the quality of the splice donor site in intron 10 and causes abnormal splicing. Sequencing of proband's cDNA revealed exon 10 skipping. Further molecular studies in the two manifesting females revealed moderate and high skewing of X inactivation. Our results support previous observation that HCFC1 variants located outside the Kelch domain exhibit dissociation of the clinical and biochemical phenotype and cause milder or no metabolic changes. We also show that this novel variant can be associated with a phenotype in females, although with milder severity, but further studies are needed to understand the role of skewed X inactivation among females in this rare disorder. Our work expands the genotypes and phenotypes associated with HCFC1-related disorder.

Entities:  

Year:  2021        PMID: 33517344     DOI: 10.1038/s10038-020-00892-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  31 in total

Review 1.  Role of host cell factor-1 in cell cycle regulation.

Authors:  Zaffer Zargar; Shweta Tyagi
Journal:  Transcription       Date:  2012-07-01

2.  A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function.

Authors:  H Goto; S Motomura; A C Wilson; R N Freiman; Y Nakabeppu; K Fukushima; M Fujishima; W Herr; T Nishimoto
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

Review 3.  The Use of Next-Generation Sequencing for Research and Diagnostics for Intellectual Disability.

Authors:  Ricardo Harripaul; Abdul Noor; Muhammad Ayub; John B Vincent
Journal:  Cold Spring Harb Perspect Med       Date:  2017-03-01       Impact factor: 6.915

4.  An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1.

Authors:  Hung-Chun Yu; Jennifer L Sloan; Gunter Scharer; Alison Brebner; Anita M Quintana; Nathan P Achilly; Irini Manoli; Curtis R Coughlin; Elizabeth A Geiger; Una Schneck; David Watkins; Terttu Suormala; Johan L K Van Hove; Brian Fowler; Matthias R Baumgartner; David S Rosenblatt; Charles P Venditti; Tamim H Shaikh
Journal:  Am J Hum Genet       Date:  2013-09-05       Impact factor: 11.025

Review 5.  Next-Generation Sequencing in Intellectual Disability.

Authors:  Gemma L Carvill; Heather C Mefford
Journal:  J Pediatr Genet       Date:  2015-10-12

6.  HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain.

Authors:  Lachlan A Jolly; Lam Son Nguyen; Deepti Domingo; Ying Sun; Simon Barry; Miroslava Hancarova; Pavlina Plevova; Marketa Vlckova; Marketa Havlovicova; Vera M Kalscheuer; Claudio Graziano; Tommaso Pippucci; Elena Bonora; Zdenek Sedlacek; Jozef Gecz
Journal:  Hum Mol Genet       Date:  2015-03-03       Impact factor: 6.150

7.  X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid.

Authors:  Emmanuel Scalais; Elise Osterheld; Christiane Weitzel; Linda De Meirleir; Frederic Mataigne; Geert Martens; Tamim H Shaikh; Curtis R Coughlin; Hung-Chun Yu; Michael Swanson; Marisa W Friederich; Gunter Scharer; Daniel Helbling; Jamie Wendt-Andrae; Johan L K Van Hove
Journal:  Pediatr Neurol       Date:  2017-01-07       Impact factor: 3.372

8.  HCF-1 amino- and carboxy-terminal subunit association through two separate sets of interaction modules: involvement of fibronectin type 3 repeats.

Authors:  A C Wilson; M Boutros; K M Johnson; W Herr
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Multiple congenital anomalies in two boys with mutation in HCFC1 and cobalamin disorder.

Authors:  M Gérard; G Morin; A Bourillon; C Colson; S Mathieu; D Rabier; T Billette de Villemeur; H Ogier de Baulny; J F Benoist
Journal:  Eur J Med Genet       Date:  2015-01-13       Impact factor: 2.708

10.  PGC-1-related coactivator complexes with HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene expression.

Authors:  Kristel Vercauteren; Natalie Gleyzer; Richard C Scarpulla
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

View more
  1 in total

Review 1.  Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C disease.

Authors:  Anna J Esser; Srijan Mukherjee; Ilia A Dereven'kov; Sergei V Makarov; Donald W Jacobsen; Ute Spiekerkoetter; Luciana Hannibal
Journal:  iScience       Date:  2022-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.